brker_guy Posted June 9, 2014 Share Posted June 9, 2014 Seth Klarman is a genius!!! ;D Link to comment Share on other sites More sharing options...
muscleman Posted June 10, 2014 Share Posted June 10, 2014 First off, congrats to those that have held this company for the past 3 months. I didn't pull the trigger at around $3.40. Do any current holders have thoughts about the future direction of the company and their current thesis to hold on to this, other than Klarman holds it? Any fair value estimates or thoughts? Thank you in advance. Yikes... I looked at this around $3.4 as well but couldn't understand it. Now looking from the rear view mirror, could anyone who has bought share some of your initial investment thesis please? Link to comment Share on other sites More sharing options...
brker_guy Posted June 10, 2014 Share Posted June 10, 2014 I think Merck really got a good deal bc look at how much Gilead paid for Pharmasset back in 2011, and IDIX' IDX20963 has proven to be for more effective than Gilead's med. http://www.bloomberg.com/news/2011-11-21/gilead-to-acquire-pharmasset-for-11-billion-to-add-hepatitis-c-medicines.html Shouldn't Idenix be valued higher if their drug is far more effective than a competitor? Now I understand why there was a bidding war for Idenix: http://www.fiercebiotech.com/story/analysis-idenix-bidding-was-competitive-driving-deal-value-eager-merck/2014-06-09 Link to comment Share on other sites More sharing options...
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now